Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases
Open Access
- 11 November 2022
- journal article
- review article
- Published by MDPI AG in Marine Drugs
- Vol. 20 (11) , 708
Abstract
Neurodegenerative diseases are growing to become one of humanity’s biggest health problems, given the number of individuals affected by them. They cause enough mortalities and severe economic impact to rival cancers and infections. With the current diversity of pathophysiological mechanisms involved in neurodegenerative diseases, on the one hand, and scarcity of efficient prevention and treatment strategies, on the other, all possible sources for novel drug discovery must be employed. Marine pharmacology represents a relatively uncharted territory to seek promising compounds, despite the enormous chemodiversity it offers. The current work discusses one vast marine region—the Northwestern or Russian Pacific—as the treasure chest for marine-based drug discovery targeting neurodegenerative diseases. We overview the natural products of neurological properties already discovered from its waters and survey the existing molecular and cellular targets for pharmacological modulation of the disease. We further provide a general assessment of the drug discovery potential of the Russian Pacific in case of its systematic development to tackle neurodegenerative diseases.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (13.1902.21.0012)
This publication has 385 references indexed in Scilit:
- Marine Pharmacology in 2009–2011: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and other Miscellaneous Mechanisms of ActionMarine Drugs, 2013
- Coibamide A Induces mTOR-Independent Autophagy and Cell Death in Human Glioblastoma CellsPLOS ONE, 2013
- Neuritogenic and Neuroprotective Effects of Polar Steroids from the Far East Starfishes Patiria pectinifera and Distolasterias niponMarine Drugs, 2013
- Regulation of AMPA receptor trafficking and synaptic plasticityCurrent Opinion in Neurobiology, 2012
- The cholinergic system and Parkinson diseaseBehavioural Brain Research, 2011
- Adenosine A2A Receptor Antagonists and Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- N-Docosahexaenoylethanolamide promotes development of hippocampal neuronsBiochemical Journal, 2011
- Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5Neuron, 2010
- Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of actionBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Marine pharmacology in 2003–4: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of actionComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2007